1. Expression profile analysis of head and neck squamous cell carcinomas using data from The Cancer Genome Atlas
   LI YAN et al, 2016 CrossRef
2. Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: New trends in the development of miRNA therapeutic strategies in oncology (Review)
   ROBERTO GAMBARI et al, 2016 CrossRef
3. MiR-504 inhibits cell proliferation and invasion by targeting LOXL2 in non small cell lung cancer
   Ming-fan Ye et al, 2018, Biomedicine & Pharmacotherapy CrossRef
4. Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs
   , 2017, IJMS CrossRef
5. MicroRNAs as effective surrogate biomarkers for early diagnosis of oral cancer
   Min Cao et al, 2018, Clin Oral Invest CrossRef
6. miR-504 promotes tumour growth and metastasis in human osteosarcoma by targeting TP53INP1.
   Qingchun Cai et al, 2017, Oncol Rep CrossRef
7. Upregulated microRNA-143 inhibits cell proliferation in human nasopharyngeal carcinoma
   Benfu He et al, 2016 CrossRef
8. A tumor-suppressive microRNA, miR-504, inhibits cell proliferation and promotes apoptosis by targeting FOXP1 in human glioma
   Run Cui et al, 2016, Cancer Letters CrossRef
9. 7-Ketocholesterol overcomes drug resistance in chronic myeloid leukemia cell lines beyond MDR1 mechanism.
   Lívia Rosa Fernandes et al, 2017, J Proteomics CrossRef
10. Overexpression of miRNA 4451 is Associated With a Poor Survival of Patients With Hypopharyngeal Cancer After Surgery With Postoperative Radiotherapy
    Xinbo Xu et al, 2018, Translational Oncology CrossRef
11. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling
    Hui Quan et al, 2018, Biomedicine & Pharmacotherapy CrossRef
12. Label-free Quantitative Analysis of Protein Expression Alterations in miR-26a-Knockout HeLa Cells using SWATH-MS Technology
    Hexiao Shen et al, 2019, Sci Rep CrossRef
13. MicroRNA-103a-3p controls proliferation and osteogenic differentiation of human adipose tissue-derived stromal cells
    Da Sol Kim et al, 2015, Exp Mol Med CrossRef
14. NEAT1 promotes colon cancer progression through sponging miR‐495‐3p and activating CDK6 in vitro and in vivo
    Zhiyun He et al, 2019, J Cell Physiol CrossRef
15. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt–β-catenin pathway
    Qiang Liu et al, 2019, J Exp Clin Cancer Res CrossRef
16. Down Regulation of miR-34a and miR-143 May Indirectly Inhibit p53 in Oral Squamous Cell Carcinoma: a Pilot Study
    Mayakannan Manikandan et al, 2015, Asian Pacific Journal of Cancer Prevention CrossRef
17. MicroRNA-203 inhibits tumour growth and metastasis through PDPN
    L. Wang et al, 2017, Clin Otolaryngol CrossRef
18. A 3‐miRNA signature predicts survival of patients with hypopharyngeal squamous cell carcinoma after post‐operative radiotherapy
    Xinbo Xu et al, 2019, J Cell Mol Med CrossRef
19. Dynamic Changes of DNA Methylation and Transcriptome Expression in Porcine Ovaries during Aging
    Xiaoyu Xi et al, 2019, BioMed Research International CrossRef
20. Investigating the epi-miRNome: identification of epi-miRNAs using transfection experiments
    Elisa Reale et al, 2019, Epigenomics CrossRef
21. MicroRNA-504 functions as a tumor suppressor in oral squamous cell carcinoma through inhibiting cell proliferation, migration and invasion by targeting CDK6
    Xiaotang Wang et al, 2019, The International Journal of Biochemistry & Cell Biology CrossRef
22. Upregulation of long non-coding RNA ROR1-AS1 promotes cell growth and migration in bladder cancer by regulation of miR-504
    Qingke Chen et al, 2020, PLoS ONE CrossRef
23. Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells
    James A. McCubrey et al, 2017, Oncotarget CrossRef
24. Blood and lung microRNAs as biomarkers of pulmonary tumorigenesis in cigarette smoke-exposed mice
    Alberto Izzotti et al, 2016, Oncotarget CrossRef
25. Zinc Gluconate Induces Potentially Cancer Chemopreventive Activity in Barrett’s Esophagus: A Phase 1 Pilot Study
    M. C. Valenzano et al, 2020, Dig Dis Sci CrossRef
26. MicroRNA‑504 targets AEG‑1 and inhibits cell proliferation and invasion in retinoblastoma
    Lina Wang et al, 2019, Mol Med Report CrossRef
27. MicroRNA‑504 modulates osteosarcoma cell chemoresistance to cisplatin by targeting p53
    Xin Chen et al, 2018, Oncol Lett CrossRef
28. The temporal effects of topical NF-κB inhibition, in the in vivo prevention of bile-related oncogenic mRNA and miRNA phenotypes in murine hypopharyngeal mucosa: a preclinical model.
    Dimitra P Vageli et al, 2020, Oncotarget CrossRef
29. Differential expression of microRNAs in the hippocampi of male and female rodents after chronic alcohol administration
    Mi Ran Choi et al, 2020, Biol Sex Differ CrossRef
30. Genome-Wide Screening and Functional Analysis Identifies Tumor Suppressor Long Noncoding RNAs Epigenetically Silenced in Hepatocellular Carcinoma
    Feiyue Xu et al, 2019, Cancer Res CrossRef
31. miR-504 Promoted Gastric Cancer Cell Proliferation and Inhibited Cell Apoptosis by Targeting RBM4
    Yi Zhang et al, 2021, Journal of Immunology Research CrossRef
32. Synthetic Evaluation of MicroRNA-1-3p Expression in Head and Neck Squamous Cell Carcinoma Based on Microarray Chips and MicroRNA Sequencing
    Yubing Chen et al, 2021, BioMed Research International CrossRef
33. MicroRNA as an Important Target for Anticancer Drug Development
    Zhiwen Fu et al, 2021, Front. Pharmacol. CrossRef
34. Bile reflux and hypopharyngeal cancer (Review)
    Dimitra Vageli et al, 2021, Oncol Rep CrossRef
35. Overexpression of microRNA-107 suppressed proliferation, migration, invasion, and the PI3K/Akt signaling pathway and induced apoptosis by targeting Nin one binding (NOB1) protein in a hypopharyngeal squamous cell carcinoma cell line (FaDu)
    Xin Gao et al, 2022, Bioengineered CrossRef
36. Exosomes and MicroRNAs in Biomedical Science
    Hamed Mirzaei et al, 2022, Synthesis Lectures on Biomedical Engineering CrossRef
37. null
    Hamed Mirzaei et al, 2022 CrossRef
38. MiR-504-3p Has Tumor-Suppressing Activity and Decreases IFITM1 Expression in Non-Small Cell Lung Cancer Cells
    Zining Liu et al, 2022, Genetic Testing and Molecular Biomarkers CrossRef
39. Downregulation of the long noncoding RNA DSCR9 (Down syndrome critical region 9) delays breast cancer progression by modulating microRNA-504-5p-dependent G protein-coupled receptor 65
    Mingzhu Li et al, 2023, Human Cell CrossRef